224 related articles for article (PubMed ID: 31308136)
41. Sex-Specific Effects of Organophosphate Diazinon on the Gut Microbiome and Its Metabolic Functions.
Gao B; Bian X; Mahbub R; Lu K
Environ Health Perspect; 2017 Feb; 125(2):198-206. PubMed ID: 27203275
[TBL] [Abstract][Full Text] [Related]
42. Gut microbiome in multiple sclerosis: The players involved and the roles they play.
Shahi SK; Freedman SN; Mangalam AK
Gut Microbes; 2017 Nov; 8(6):607-615. PubMed ID: 28696139
[TBL] [Abstract][Full Text] [Related]
43. Local and Long-Distance Calling: Conversations between the Gut Microbiota and Intra- and Extra-Gastrointestinal Tract Infections.
Denny JE; Powell WL; Schmidt NW
Front Cell Infect Microbiol; 2016; 6():41. PubMed ID: 27148490
[TBL] [Abstract][Full Text] [Related]
44. Gut microbiome and its role in cardiovascular diseases.
Ahmadmehrabi S; Tang WHW
Curr Opin Cardiol; 2017 Nov; 32(6):761-766. PubMed ID: 29023288
[TBL] [Abstract][Full Text] [Related]
45. Gut microbiome diversity is associated with sleep physiology in humans.
Smith RP; Easson C; Lyle SM; Kapoor R; Donnelly CP; Davidson EJ; Parikh E; Lopez JV; Tartar JL
PLoS One; 2019; 14(10):e0222394. PubMed ID: 31589627
[TBL] [Abstract][Full Text] [Related]
46. A Molecular-Level Landscape of Diet-Gut Microbiome Interactions: Toward Dietary Interventions Targeting Bacterial Genes.
Ni Y; Li J; Panagiotou G
mBio; 2015 Oct; 6(6):e01263-15. PubMed ID: 26507230
[TBL] [Abstract][Full Text] [Related]
47. Gut Microbiome in Chronic Kidney Disease.
Armani RG; Ramezani A; Yasir A; Sharama S; Canziani MEF; Raj DS
Curr Hypertens Rep; 2017 Apr; 19(4):29. PubMed ID: 28343357
[TBL] [Abstract][Full Text] [Related]
48. The Gut Microbiome and Obesity.
John GK; Mullin GE
Curr Oncol Rep; 2016 Jul; 18(7):45. PubMed ID: 27255389
[TBL] [Abstract][Full Text] [Related]
49. Bacteria-Bacteriophage Coevolution in the Human Gut: Implications for Microbial Diversity and Functionality.
Scanlan PD
Trends Microbiol; 2017 Aug; 25(8):614-623. PubMed ID: 28342597
[TBL] [Abstract][Full Text] [Related]
50. Evolutionary change in the human gut microbiome: From a static to a dynamic view.
Gordo I
PLoS Biol; 2019 Feb; 17(2):e3000126. PubMed ID: 30730933
[TBL] [Abstract][Full Text] [Related]
51. The organophosphate malathion disturbs gut microbiome development and the quorum-Sensing system.
Gao B; Chi L; Tu P; Bian X; Thomas J; Ru H; Lu K
Toxicol Lett; 2018 Feb; 283():52-57. PubMed ID: 29097220
[TBL] [Abstract][Full Text] [Related]
52. Biotechnology of health-promoting bacteria.
Douillard FP; de Vos WM
Biotechnol Adv; 2019 Nov; 37(6):107369. PubMed ID: 30876799
[TBL] [Abstract][Full Text] [Related]
53. The altered gut virome community in rhesus monkeys is correlated with the gut bacterial microbiome and associated metabolites.
Li H; Li H; Wang J; Guo L; Fan H; Zheng H; Yang Z; Huang X; Chu M; Yang F; He Z; Li N; Yang J; Wu Q; Shi H; Liu L
Virol J; 2019 Aug; 16(1):105. PubMed ID: 31426820
[TBL] [Abstract][Full Text] [Related]
54. Microbiome of HIV-infected people.
Dubourg G; Surenaud M; Lévy Y; Hüe S; Raoult D
Microb Pathog; 2017 May; 106():85-93. PubMed ID: 27216237
[TBL] [Abstract][Full Text] [Related]
55. The human gut microbiome as source of innovation for health: Which physiological and therapeutic outcomes could we expect?
Doré J; Multon MC; Béhier JM;
Therapie; 2017 Feb; 72(1):21-38. PubMed ID: 28131442
[TBL] [Abstract][Full Text] [Related]
56. Impact of Dietary Resistant Starch on the Human Gut Microbiome, Metaproteome, and Metabolome.
Maier TV; Lucio M; Lee LH; VerBerkmoes NC; Brislawn CJ; Bernhardt J; Lamendella R; McDermott JE; Bergeron N; Heinzmann SS; Morton JT; González A; Ackermann G; Knight R; Riedel K; Krauss RM; Schmitt-Kopplin P; Jansson JK
mBio; 2017 Oct; 8(5):. PubMed ID: 29042495
[TBL] [Abstract][Full Text] [Related]
57. Effects of the Artificial Sweetener Neotame on the Gut Microbiome and Fecal Metabolites in Mice.
Chi L; Bian X; Gao B; Tu P; Lai Y; Ru H; Lu K
Molecules; 2018 Feb; 23(2):. PubMed ID: 29425148
[TBL] [Abstract][Full Text] [Related]
58. The Impact of the Fecal Microbiome on Cancer Immunotherapy.
Osman AEG; Luke JJ
BioDrugs; 2019 Feb; 33(1):1-7. PubMed ID: 30604388
[TBL] [Abstract][Full Text] [Related]
59. Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice.
Brown K; Godovannyi A; Ma C; Zhang Y; Ahmadi-Vand Z; Dai C; Gorzelak MA; Chan Y; Chan JM; Lochner A; Dutz JP; Vallance BA; Gibson DL
ISME J; 2016 Feb; 10(2):321-32. PubMed ID: 26274050
[TBL] [Abstract][Full Text] [Related]
60. Oral Administration of Porphyromonas gingivalis Alters the Gut Microbiome and Serum Metabolome.
Kato T; Yamazaki K; Nakajima M; Date Y; Kikuchi J; Hase K; Ohno H; Yamazaki K
mSphere; 2018 Oct; 3(5):. PubMed ID: 30333180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
